Companies
JIRCAS
the global BNI-maize assessment published in Environmental Research Letters (July 2026) includes Corteva-aligned authors alongside JIRCAS and CIMMYT, modelling a pathway to commercial BNI-maize hybrids.
- Country
- Japan
Research
Coverage
| CN | EU | US | |
|---|---|---|---|
| agri-inputs-biocontrol | ✓ | ✓ | ✓ |
Regulatorsepaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Affiliation | Japan International Research Center for Agricultural Sciences (JIRCAS) | cgspace.cgiar.org · doi.org · cimmyt.org · jircas.go.jp |
| Research focus | Biological Nitrification Inhibition (BNI) technology in crops including maize and wheat | doi.org · iopscience.iop.org · jircas.go.jp |
| Facility | Tropical Agriculture Research Front (TARF) in Ishigaki, Okinawa, Japan | opportunitiesforyouth.org · jircas.go.jp |
| Facility | Tsukuba International House (TIH), Tsukuba, Japan | opportunitiesforyouth.org |
| Grant | Novo Nordisk Foundation mission funding for CropSustaiN BNI Wheat Mission | cimmyt.org |
| Publications | The impacts of biological nitrification inhibition-enabled maize on global nitrogen fertilizer consumption and greenhouse gas emissions (Environmental Research Letters, July 2026) | doi.org · iopscience.iop.org |
| Principal staff | Ai Leon (JIRCAS) | doi.org · iopscience.iop.org · preview-www.nature.com |
| Principal staff | Guntur V. Subbarao (JIRCAS) | doi.org · iopscience.iop.org · preview-www.nature.com |
| Principal staff | Tadashi Yoshihashi (JIRCAS) | doi.org · iopscience.iop.org · preview-www.nature.com |
Independent sources: cgspace.cgiar.org · cimmyt.org · doi.org · iopscience.iop.org · opportunitiesforyouth.org · preview-www.nature.com
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biological nitrification inhibitors | agri-inputs-biocontrol | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.